Buch Barbara
Division of General, Restorative, and Neurological Devices, Office of Device Evaluation, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, MD 20850, USA.
Am J Orthop (Belle Mead NJ). 2007 Aug;36(8):407-12.
The Food and Drug Administration (FDA) does more than regulate food and drug products. Through its medical device evaluation process, FDA affects every orthopedic surgeon's practice and every orthopedic patient every day. FDA regulations affect the development of each orthopedic device in some way, from the product's inception to its senescence, but the regulatory process and what the FDA's stamp of approval means are not part of the curriculum in medical school or residency. Each device follows a specific pathway from manufacture to physician use and patient care depending on the assessment of risk associated with the device or classes of devices. The evaluation of safety and effectiveness involves a complex process of biomechanical, engineering, preclinical, laboratory, clinical, and epidemiological assessment. How different types of devices get to the patient are reviewed, and the basics of the regulatory process are explained in this paper. Common myths are set straight, and FDA's concerns with "off-label" use are discussed. The role of the orthopedic surgeon in the regulatory process is also introduced.
美国食品药品监督管理局(FDA)的职责远不止于监管食品和药品。通过其医疗器械评估程序,FDA每天都在影响着每位骨科医生的临床实践以及每位骨科患者。FDA的法规以某种方式影响着每一款骨科器械的研发,从产品诞生到其淘汰,但监管流程以及FDA的批准标志意味着什么,并非医学院或住院医师培训课程的一部分。每一款器械从生产到医生使用以及患者护理都遵循特定的路径,这取决于对该器械或器械类别的相关风险评估。安全性和有效性评估涉及生物力学、工程学、临床前、实验室、临床和流行病学评估等复杂过程。本文将回顾不同类型的器械如何应用于患者,并解释监管流程的基本要点。纠正常见的误解,并讨论FDA对“未标靶”使用的关注。还将介绍骨科医生在监管过程中的作用。